ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 174 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $944,704 | +28.1% | 6,927 | +42.0% | 0.01% | +9.1% |
Q1 2024 | $737,558 | +17.0% | 4,879 | -2.6% | 0.01% | +22.2% |
Q4 2023 | $630,632 | +27.5% | 5,007 | -5.2% | 0.01% | +12.5% |
Q3 2023 | $494,794 | -0.5% | 5,284 | -5.1% | 0.01% | +14.3% |
Q2 2023 | $497,123 | -19.9% | 5,570 | -3.7% | 0.01% | -30.0% |
Q1 2023 | $620,482 | -13.7% | 5,787 | -1.7% | 0.01% | -16.7% |
Q4 2022 | $719,346 | -6.8% | 5,890 | -21.2% | 0.01% | -14.3% |
Q3 2022 | $772,000 | +7.1% | 7,476 | -3.6% | 0.01% | +16.7% |
Q2 2022 | $721,000 | -45.9% | 7,757 | -31.7% | 0.01% | -36.8% |
Q1 2022 | $1,333,000 | -17.9% | 11,359 | -5.9% | 0.02% | -13.6% |
Q4 2021 | $1,624,000 | -22.8% | 12,074 | -8.5% | 0.02% | -26.7% |
Q3 2021 | $2,103,000 | +55.5% | 13,195 | +28.4% | 0.03% | +57.9% |
Q2 2021 | $1,352,000 | +34.1% | 10,277 | +31.4% | 0.02% | +18.8% |
Q1 2021 | $1,008,000 | +34.8% | 7,823 | +74.5% | 0.02% | +33.3% |
Q4 2020 | $748,000 | +106.1% | 4,484 | +90.7% | 0.01% | +71.4% |
Q3 2020 | $363,000 | +81.5% | 2,351 | +73.5% | 0.01% | +75.0% |
Q2 2020 | $200,000 | +308.2% | 1,355 | +210.1% | 0.00% | +300.0% |
Q1 2020 | $49,000 | – | 437 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |